Search Within

Sandra Pierina D'Angelo

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (136)
  2. Journal Article (105)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (1)
  6. Book Whole (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (253)
  2. Hematologic Malignancies, Division of (253)
  3. Sarcoma Service (253)
  4. Solid Tumor Oncology Division (253)
  5. GSK Faculty (102)
  6. Tow Center for Developmental Oncology (TCDO) (89)

More Groups

People
  1. William Tap (105)
  2. Mark Dickson (84)
  3. Mrinal Gounder (73)
  4. Mary Keohan (71)
  5. Ping Chi (59)
  6. Cristina Antonescu (53)

More People

Years
  1. 2025 (6)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (32)
  5. 2021 (16)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Journal for ImmunoTherapy of Cancer (23)
  3. Annals of Oncology (16)
  4. Clinical Cancer Research (12)
  5. JAMA Oncology (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (103)
  2. Biomed Central Ltd (25)
  3. Oxford University Press (20)
  4. American Association for Cancer Research (19)
  5. Elsevier Inc. (16)
  6. Springer (9)

More Publishers

Results (253)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma, myxoid/round cell liposarcoma and nonsmall cell lung cancer [Substudy 1 (GSK3901961) and Substudy 2 (GSK3845097)]
    Meeting Abstract

    Ullrich, R.; Wermke, M.; Yachnin, J.; Mielke, S.; Patel, R.; Yushak, M. L.; Schoenfeld, A. J.; Desai, J.; Altan, M.; D'Angelo, S. P.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Thornton, K. A.; Movva, S.; Nacev, B. A.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Nacev, B. A.; Rosenbaum, E.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition
    Meeting Abstract

    Nacev, B. A.; Bradic, M.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identification of response stratification factors from pooled efficacy analyses of afamitresgene autoleucel ("Afami-cel" [Formerly ADP-A2M4]) in metastatic synovial sarcoma and myxoid/round cell liposarcoma phase 1 and phase 2 trials
    Meeting Abstract

    D'Angelo, S. P.; Attia, S.; Blay, J. Y.; Strauss, S. J.; Morales, C. M. V.; Razak, A. R. A.; Van Winkle, E.; Annareddy, T.; Sattigari, C.; Diamantopoulos, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Primary efficacy and safety of letetresgene autoleucel (lete-cel; GSK3377794) pilot study in patients with advanced and metastatic myxoid/round cell liposarcoma (MRCLS)
    Meeting Abstract

    D'Angelo, S. P.; Druta, M.; Van Tine, B. A.; Liebner, D. A.; Schuetze, S.; Nathenson, M.; Holmes, A. P.; D'Souza, J.; Kapoor, G. S.; Zajic, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and myxoid/round cell liposarcoma [Substudy 3, GSK4427296]
    Meeting Abstract

    Araujo, D. M.; Ladle, B. H.; He, K.; Powers, B.; McGillivray, A.; Mitrica, I.; Liu, W.; Patel, N.; D'Angelo, S. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4])
    Meeting Abstract

    Lunt, C.; D'Angelo, S. P.; Razak, A. R. A.; Wagner, M. J.; Van Tine, B. A.; Ganjoo, K.; Blay, J. Y.; Araujo, D. M.; Agulnik, M.; Glod, J. W.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save